This inventor holds 1 USPTO granted patent. Top assignees: Sumitomo Chemical Company, Limited, Other. Active years: 1985.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6,965 
1 out of 834,601 Years Active: 1985
Title: The Innovations of Tomoyoshi Kondo
Introduction
Tomoyoshi Kondo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. His innovative approach has led to the development of a unique antiparkinsonian agent.
Latest Patents
Kondo holds a patent for an antiparkinsonian agent that comprises DL- or L-threo-3,4-dihydroxyphenylserine and a decarboxylase inhibitor, such as carbidopa and benserazide. This invention is particularly useful for treating Parkinson's disease, especially addressing the freezing phenomenon that has not been effectively managed by conventional antiparkinsonian drugs like L-DOPA. He has 1 patent to his name.
Career Highlights
Throughout his career, Kondo has worked with prominent organizations, including Sumitomo Chemical Company, Limited. His work has been instrumental in advancing medical treatments and improving the quality of life for individuals suffering from Parkinson's disease.
Collaborations
Kondo has collaborated with esteemed colleagues such as Tomokazu Suzuki and Hirotaro Narabayashi. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Tomoyoshi Kondo's contributions to the field of medicine through his innovative inventions highlight the importance of research and development in treating complex diseases. His work continues to inspire advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile